A study presents battery-free, polymer-based wearable devices that wrap around neurons, allowing for real-time monitoring and modulation of cellular activity. This innovation aims to restore neuronal function in conditions like multiple sclerosis.
This development comes from…
Researchers have designed a high-speed 3D bioprinter to accurately print human tissues.
Continue reading “New high-speed 3D bioprinter uses acoustics to print human tissues” »
MIT researchers have developed a battery-free, subcellular-sized device made of polymer designed to measure and modulate a neuron’s electrical and metabolic activity. When the device is activated by light, it can gently wrap around the neuron cell’s axons and dendrites without damaging the cells.
Scientists want to inject thousands of these tiny wireless devices into a patient’s central nervous system and then actuate them noninvasively using light. The light would penetrate the tissue and allow precise control of the devices, and thereby restore function in cases of neuronal degradation like multiple sclerosis (MS).
The MIT researchers developed these thin-film devices from a azobenzene, a soft polymer that readily reacts to light. Thin sheets of azobenzene roll into a cylinder when exposed to light, which enables them to wrap around cells. Researchers can control the direction and diameter of the rolling by changing the intensity and polarization of the light, producing a microtube with a diameter smaller than one micrometer.
Ionut Constantinescu, Tiago Pimentel, Ryan Cotterell, Alex Warstadt ETH Zurich 2024 https://arxiv.org/abs/2407.
Children are better at learning a…
We’ve detected that JavaScript is disabled in this browser. Please enable JavaScript or switch to a supported browser to continue using x.com. You can see a list of supported browsers in our Help Center.
The intricate relationship between hydrogen sulfide (H2S), gut microbiota, and sirtuins (SIRTs) can be seen as a paradigm axis in maintaining cellular homeostasis, modulating oxidative stress, and promoting mitochondrial health, which together play a pivotal role in aging and neurodegenerative diseases. H2S, a gasotransmitter synthesized endogenously and by specific gut microbiota, acts as a potent modulator of mitochondrial function and oxidative stress, protecting against cellular damage. Through sulfate-reducing bacteria, gut microbiota influences systemic H2S levels, creating a link between gut health and metabolic processes. Dysbiosis, or an imbalance in microbial populations, can alter H2S production, impair mitochondrial function, increase oxidative stress, and heighten inflammation, all contributing factors in neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
The small-scale FDA-cleared trial is designed to evaluate both the safety and initial efficacy of RB-ADSCs in nine patients with Alzheimer’s. Regeneration Biomedical’s CTAD presentation focused on the first three enrolled patients, who each received a single dose of RB-ADSCs delivered directly into the lateral ventricles of the brain using an “Ommaya reservoir” – a device implanted under the scalp to bypass the blood-brain barrier, a major obstacle in Alzheimer’s treatments.
Biomarker analysis at the 12-week mark demonstrated reductions in both p-Tau and amyloid-beta – two proteins strongly associated with Alzheimer’s disease progression. In cerebrospinal fluid (CSF) samples from the three patients, p-Tau levels decreased to “normal” levels, while amyloid PET scans also showed a reduction in amyloid buildup.
Regeneration Biomedical also reported its treatment produced signs of cognitive improvement, with two of the three patients showing increased Mini-Mental State Examination (MMSE) scores, a common measure of cognitive function.
Ever noticed how you catch a falling glass before it even registers that it’s slipping? That’s because your brain is constantly making predictions, keeping you one step ahead of reality.
As difficult as it may be to believe, our minds don’t just process what’s happening — they anticipate what’s about to happen next.
This intriguing concept comes from researchers Christian Keysers and Valeria Gazzola of the Netherlands Institute for Neuroscience, along with Giorgia Silani from the University of Vienna.
Dr. Abba Zubair, MD: “Our hope is to study these space-grown cells to improve treatment for age-related conditions such as stroke, dementia, neurodegenerative diseases and cancer.”
What can microgravity teach us about stem cell growth? This is what a recent study published in NPJ Microgravity hopes to address as a pair of researchers from the Mayo Clinic investigated past research regarding the growth properties of stem cells, specifically regeneration, differentiation, and cell proliferation in microgravity and whether the stem cells can maintain these properties after returning to Earth. This study holds the potential to help researchers better understand how stem cell growth in microgravity can be transitioned into medical applications, including tissue growth for disease modeling.
“The goal of almost all space flight in which stem cells are studied is to enhance growth of large amounts of safe and high-quality clinical-grade stem cells with minimal cell differentiation,” said Dr. Abba Zubair, MD, who is a faculty at the Mayo Clinic and the sole co-author on the study. “Our hope is to study these space-grown cells to improve treatment for age-related conditions such as stroke, dementia, neurodegenerative diseases and cancer.”
Continue reading “Space-Born Stem Cells: A New Frontier in Regenerative Medicine” »
“Badass”. That was the word Harvard University neuroscientist Steve Ramirez used in a Tweet to describe research published online by fellow neuroscientist Ali Güler and colleagues in the journal Nature Neuroscience last March. Güler’s group, based at the University of Virginia in the US, reported having altered the behaviour of mice and other animals by using a magnetic field to remotely activate certain neurons in their brains. For Ramirez, the research was an exciting step forward in the emerging field of “magnetogenetics”, which aims to use genetic engineering to render specific regions of the brain sensitive to magnetism – in this case by joining proteins containing iron with others that control the flow of electric current through nerve-cell membranes.
By allowing neurons deep in the brain to be switched on and off quickly and accurately as well as non-invasively, Ramirez says that magnetogenetics could potentially be a boon for our basic understanding of behaviour and might also lead to new ways of treating anxiety and other psychological disorders. Indeed, biologist Kenneth Lohmann of the University of North Carolina in the US says that if the findings of Güler and co-workers are confirmed then magnetogenetics would constitute a “revolutionary new tool in neuroscience”
The word “if” here is important. In a paper posted on the arXiv preprint server in April last year and then published in a slightly revised form in the journal eLife last August, physicist-turned-neuroscientist Markus Meister of the California Institute of Technology laid out a series of what he describes as “back-of-the-envelope” calculations to check the physical basis for the claims made in the research. He did likewise for an earlier magnetogenetics paper published by another group in the US as well as for research by a group of scientists in China positing a solution to the decades-old problem of how animals use the Earth’s magnetic field to navigate – papers that were also published in Nature journals.
MIT’s new tiny wearables wrap around neurons to monitor or heal, opening new treatments for brain diseases like multiple sclerosis.
